|
Dilon touts BSGI research from NCBC
 March 27, 2012 -- Dilon Diagnostics is directing attention to a recent multicenter patient registry that found that its BSGI technology improves breast cancer detection when added to mammography and ultrasound in the breast clinic.
To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
| |
|
|
New AuntMinnie.com Members
|
Becoming a Member is FREE!
|
Real-time radiology-specific news
Case of the Day and Teaching Files
Focused topics digital communities
Lively, discussion groups
Medical imaging bookstore
SalaryScan
Job Boards
OnLine CMe/CE
Bookstore, market reports, more …
Conference Calendar
User-controlled eNewsletters
… registration is FREE and easy!
|
| |
|
In the study, presented at the National Consortium of Breast Centers (NCBC) annual meeting earlier this month, BSGI detected cancers in nearly 13% of patients with negative or indeterminate mammograms and an unresolved diagnostic concern. BSGI detected a high-risk lesion in 4% of these patients, according to Dilon.
Furthermore, BSGI detected 92% of cancers, outperforming ultrasound's 60% cancer detection rate, Dilon said.
Study co-author Dr. Jean Weigert of Mandell and Blau MDs in New Britain, CT, said that the results demonstrate that BSGI can detect some cancers in cases where mammography and ultrasound are negative or indeterminate. | |
|